Longchuan Bai

Person

Ann Arbor, MI, US

People

Patents Grantslast 30 patents

Information Patent Grant
Fused 1,4-oxazepines as BET protein degraders
- Patent number 11,466,028
- Issue date Oct 11, 2022
- The Regents of the University of Michigan
- Shaomeng Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
BET bromodomain protein degraders with cleavable linkers
- Patent number 11,267,822
- Issue date Mar 8, 2022
- The Regents of the University of Michigan
- Shaomeng Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monofunctional intermediates for ligand-dependent target protein de...
- Patent number 10,759,808
- Issue date Sep 1, 2020
- The Regents of the University of Michigan
- Shaomeng Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
BET protein degraders
- Patent number 10,633,386
- Issue date Apr 28, 2020
- The Regents of the University of Michigan
- Shaomeng Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
BET bromodomain inhibitors and therapeutic methods using the same
- Patent number 10,391,175
- Issue date Aug 27, 2019
- The Regents of the University of Michigan
- Shaomeng Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
9H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain i...
- Patent number 10,253,044
- Issue date Apr 9, 2019
- The Regents of the University of Michigan
- Shaomeng Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indoloquinolone compounds as anaplastic lymphoma kinase (ALK) inhib...
- Patent number 9,783,539
- Issue date Oct 10, 2017
- Jiangsu Ascentage Biomed Development Inc.
- Jianyong Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
BET bromodomain inhibitors and therapeutic methods using the same
- Patent number 9,675,697
- Issue date Jun 13, 2017
- The Regents of the University of Michigan
- Shaomeng Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
9H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain in...
- Patent number 9,580,430
- Issue date Feb 28, 2017
- The Regents of the University of Michigan
- Shaomeng Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same
- Patent number 9,403,856
- Issue date Aug 2, 2016
- The Regents of the University of Michigan
- Shaomeng Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
BCL-2/BCL-XL inhibitors and therapeutic methods using the same
- Patent number 9,096,625
- Issue date Aug 4, 2015
- The Regents of the University of Michigan
- Shaomeng Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same
- Patent number 8,691,184
- Issue date Apr 8, 2014
- The Regents of the University of Michigan
- Shaomeng Wang
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Cereblon Ligands and Uses Thereof
- Publication number 20240059704
- Publication date Feb 22, 2024
- Regents of the University of Michigan
- Shaomeng Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cereblon Ligands and Uses Thereof
- Publication number 20240059711
- Publication date Feb 22, 2024
- Regents of the University of Michigan
- Shaomeng Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STAT5 and STAT6 Inhibitors and Uses Thereof
- Publication number 20230295200
- Publication date Sep 21, 2023
- Regents of the University of Michigan
- Shaomeng Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STAT5 and STAT6 Degraders and Uses Thereof
- Publication number 20230295197
- Publication date Sep 21, 2023
- REGENTS OF THE UNIVERSITY OF MICHICAN
- Shaomeng Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SMALL MOLECULE STAT PROTEIN DEGRADERS
- Publication number 20230159573
- Publication date May 25, 2023
- The Regents of the University of Michigan
- Shaomeng Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD OF TREATING GRAFT-VERSUS-HOST DISEASE
- Publication number 20230133504
- Publication date May 4, 2023
- Regents of the University of Michigan
- Pavan Reddy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SMALL MOLECULE DEGRADERS OF STAT3
- Publication number 20230083015
- Publication date Mar 16, 2023
- The Regents of the University of Michigan
- Shaomeng Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED 1,4-OXAZEPINES AS BET PROTEIN DEGRADERS
- Publication number 20210284657
- Publication date Sep 16, 2021
- The Regents of the University of Michigan
- Shaomeng Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOFUNCTIONAL INTERMEDIATES FOR LIGAND-DEPENDENT TARGET PROTEIN DE...
- Publication number 20210002289
- Publication date Jan 7, 2021
- The Regents of the University of Michigan
- Yangbing Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BET Bromodomain Protein Degraders with Cleavable Linkers
- Publication number 20200277305
- Publication date Sep 3, 2020
- The Regents of the University of Michigan
- Shaomeng Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BET PROTEIN DEGRADERS
- Publication number 20190169195
- Publication date Jun 6, 2019
- The Regents of the University of Michigan
- Shaomeng Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOFUNCTIONAL INTERMEDIATES FOR LIGAND-DEPENDENT TARGET PROTEIN DE...
- Publication number 20190119289
- Publication date Apr 25, 2019
- The Regents of the University of Michigan
- Shaomeng Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BET BROMODOMAIN INHIBITORS AND THERAPEUTIC METHODS USING THE SAME
- Publication number 20170281773
- Publication date Oct 5, 2017
- The Regents of the University of Michigan
- Shaomeng Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
9H-PYRIMIDO [4,5-B]INDOLES AND RELATED ANALOGS AS BET BROMODOMAIN I...
- Publication number 20170210761
- Publication date Jul 27, 2017
- The Regents of the University of Michigan
- Shaomeng Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INDOLOQUINOLONE COMPOUNDS AS ANAPLASTIC LYMPHOMA KINASE (ALK) INHIB...
- Publication number 20170066761
- Publication date Mar 9, 2017
- Jiangsu Ascentage Biomed Development Inc.
- Jianyong CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BCL-2/BCL-XL INHIBITORS AND THERAPEUTIC METHODS USING THE SAME
- Publication number 20150336994
- Publication date Nov 26, 2015
- The Regents of the University of Michigan
- Shaomeng Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
9H-PYRIMIDO[4,5-B]INDOLES AND RELATED ANALOGS AS BET BROMODOMAIN IN...
- Publication number 20150246923
- Publication date Sep 3, 2015
- The Regents of the University of Michigan
- Shaomeng Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BET BROMODOMAIN INHIBITORS AND THERAPEUTIC METHODS USING THE SAME
- Publication number 20140256706
- Publication date Sep 11, 2014
- The Regents of the University of Michigan
- Shaomeng Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BCL-2/BCL-XL INHIBITORS AND THERAPEUTIC METHODS USING THE SAME
- Publication number 20140199234
- Publication date Jul 17, 2014
- The Regents of the University of Michigan
- Shaomeng Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOMARKERS FOR GOSSYPOL CHEMOTHERAPY AND METHODS OF TREATING DISEASE
- Publication number 20120302629
- Publication date Nov 29, 2012
- The Regents of the University of Michigan
- Shaomeng Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BCL-2/BCL-XL INHIBITORS AND THERAPEUTIC METHODS USING THE SAME
- Publication number 20120189539
- Publication date Jul 26, 2012
- The Regents of University of Michigan
- Shaomeng Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STAT3 LIGANDS AND THERAPEUTIC USES THEREOF
- Publication number 20110319362
- Publication date Dec 29, 2011
- Shaomeng Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Longchuan Bai

Person

Patents Grantslast 30 patents

Fused 1,4-oxazepines as BET protein degraders

BET bromodomain protein degraders with cleavable linkers

Monofunctional intermediates for ligand-dependent target protein de...

BET protein degraders

BET bromodomain inhibitors and therapeutic methods using the same

9H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain i...

Indoloquinolone compounds as anaplastic lymphoma kinase (ALK) inhib...

BET bromodomain inhibitors and therapeutic methods using the same

9H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain in...

Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same

BCL-2/BCL-XL inhibitors and therapeutic methods using the same

Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same

Patents Applicationslast 30 patents

Cereblon Ligands and Uses Thereof

Cereblon Ligands and Uses Thereof

STAT5 and STAT6 Inhibitors and Uses Thereof

STAT5 and STAT6 Degraders and Uses Thereof

SMALL MOLECULE STAT PROTEIN DEGRADERS

METHOD OF TREATING GRAFT-VERSUS-HOST DISEASE

SMALL MOLECULE DEGRADERS OF STAT3

FUSED 1,4-OXAZEPINES AS BET PROTEIN DEGRADERS

MONOFUNCTIONAL INTERMEDIATES FOR LIGAND-DEPENDENT TARGET PROTEIN DE...

BET Bromodomain Protein Degraders with Cleavable Linkers

BET PROTEIN DEGRADERS

MONOFUNCTIONAL INTERMEDIATES FOR LIGAND-DEPENDENT TARGET PROTEIN DE...

BET BROMODOMAIN INHIBITORS AND THERAPEUTIC METHODS USING THE SAME

9H-PYRIMIDO [4,5-B]INDOLES AND RELATED ANALOGS AS BET BROMODOMAIN I...

INDOLOQUINOLONE COMPOUNDS AS ANAPLASTIC LYMPHOMA KINASE (ALK) INHIB...

BCL-2/BCL-XL INHIBITORS AND THERAPEUTIC METHODS USING THE SAME

9H-PYRIMIDO[4,5-B]INDOLES AND RELATED ANALOGS AS BET BROMODOMAIN IN...

BET BROMODOMAIN INHIBITORS AND THERAPEUTIC METHODS USING THE SAME

BCL-2/BCL-XL INHIBITORS AND THERAPEUTIC METHODS USING THE SAME

BIOMARKERS FOR GOSSYPOL CHEMOTHERAPY AND METHODS OF TREATING DISEASE

BCL-2/BCL-XL INHIBITORS AND THERAPEUTIC METHODS USING THE SAME

STAT3 LIGANDS AND THERAPEUTIC USES THEREOF